What is Beam Therapeutics's total equity?

Beam Therapeutics (BEAM) reported total equity of $1.16B in Q1 2026.

How has Beam Therapeutics's total equity changed year-over-year?

Beam Therapeutics's total equity increased by 3.1% year-over-year, from $1.13B to $1.16B.

What is the long-term trend for Beam Therapeutics's total equity?

Over 5 years (2020 to 2025), Beam Therapeutics's total equity has grown at a 38.2% compound annual growth rate (CAGR), from $245.56M to $1.24B.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Beam Therapeutics BEAM Total Equity

Total Equity at other companies

Vertex PharmaceuticalsVRTX

$19.36B+17.4%

Arrowhead ResearchARWR

$613.98M-10.1%

CRISPR TherapeuticsCRSP

$1.81B-0.8%

Cogent Biosciences, Inc.COGT

$607.69M+177%

PTC TherapeuticsPTCT

-$180.47M+2.9%

BridgeBio PharmaBBIO

-$2.28B-38.2%

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.51B+24.5%

Enterprise value$3.47B+51.2%

P/S21.4×-23.0×

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's total equity?: Beam Therapeutics (BEAM) reported total equity of $1.16B in Q1 2026.
How has Beam Therapeutics's total equity changed year-over-year?: Beam Therapeutics's total equity increased by 3.1% year-over-year, from $1.13B to $1.16B.
What is the long-term trend for Beam Therapeutics's total equity?: Over 5 years (2020 to 2025), Beam Therapeutics's total equity has grown at a 38.2% compound annual growth rate (CAGR), from $245.56M to $1.24B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.